NICOLE STRAND: Open Payments
NPI 1407367212 · ORANGE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,757 in 215 payments from 21 companies in 2025. Trend: 2023 $3,271 · 2024 $5,298 · 2025 $4,757
Food & beverage: $4,617Education: $140
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $865 |
| Regeneron Healthcare Solutions, Inc. | 16 | $509 |
| Incyte Corporation | 25 | $436 |
| Janssen Biotech, Inc. | 14 | $423 |
| PFIZER INC. | 19 | $395 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 17 | $338 |
| LEO Pharma Inc. | 12 | $263 |
| Galderma Laboratories, L.P. | 9 | $235 |
| Lilly USA, LLC | 9 | $228 |
| UCB, Inc. | 10 | $218 |
Products named: DUPIXENT, RINVOQ, OPZELURA, TREMFYA, CIBINQO, SKYRIZI, NEMLUVIO, Bimzelx.
Industry payments across CT — which companies pay providers there.
